4.6 Article

Identification of Human Endogenous Retrovirus-Specific T Cell Responses in Vertically HIV-1-Infected Subjects

Journal

JOURNAL OF VIROLOGY
Volume 85, Issue 21, Pages 11526-11531

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.05418-11

Keywords

-

Categories

Funding

  1. Pfizer
  2. NIH/NIAID [RO1 AI087145, K24AI069994, AI76059, AI84113]
  3. CFAR Network of Integrated Clinical Systems (CNICS) [1 R24 AI067039-1]
  4. UCSF Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR)
  5. NIH [P30 AI027763]
  6. Fogarty International Center [D43 TW00003]
  7. UCSF Clinical and Translational Science Institute [UL1 RR024131]
  8. American Foundation for AIDS Research [106710-40-RGRL]
  9. Ragon Institute, Boston, MA

Ask authors/readers for more resources

Human endogenous retrovirus (HERV)-specific T cell responses in HIV-1-infected adults have been reported. Whether HERV-specific immunity exists in vertically HIV-1-infected children is unknown. We performed a cross-sectional analysis of HERV-specific T cell responses in 42 vertically HIV-1-infected children. HERV (-H, -K, and -L family)-specific T cell responses were identified in 26 of 42 subjects, with the greatest magnitude observed for the responses to HERV-L. These HERV-specific T cell responses were inversely correlated with the HIV-1 plasma viral load and positively correlated with CD4(+) T cell counts. These data indicate that HERV-specific T cells may participate in controlling HIV-1 replication and that certain highly conserved HERV-derived proteins may serve as promising therapeutic vaccine targets in HIV-1-infected children.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available